申请人:PFIZER INC.
公开号:US20130252961A1
公开(公告)日:2013-09-26
The invention relates to compounds of formula (Φ)
as further defined herein and to the pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising such compounds and salts, and to the uses thereof. The compounds and salts of the present invention inhibit anaplastic lymphoma kinase (ALK) and/or EML4-ALK and are useful for treating or ameliorating abnormal cell proliferative disorders, such as cancer.
本发明涉及公式(Φ)的化合物,如此处进一步定义的,并涉及其药学上可接受的盐,包括含有这种化合物和盐的制药组合物,以及其用途。本发明的化合物和盐抑制无形淋巴瘤激酶(ALK)和/或EML4-ALK,并可用于治疗或改善异常细胞增殖性疾病,如癌症。